Sarepta Therapeutics (SRPT) Q3 2016 Earnings

19JulConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-1.44
-1.35
-1.26
-1.17

Details

Expected EPS
-1.23
Actual EPS
-1.35
Surprise EPS
-0.12
Surprise Percent
+9.76%

Description

Sarepta Therapeutics (SRPT) has reported earnings of -1.35 per share for Q3 2016.

0 Comments

Share your thoughts